Long-term resource utilisation and associated costs of exercise during (neo)adjuvant oncological treatment: the Phys-Can project.
Anna-Karin AxMagnus HusbergBirgitta Beda Kristina JohanssonHenrik LindmanSveinung BerntsenKatarina SjövallSussanne BörjesonKarin NordinThomas DavidsonPublished in: Acta oncologica (Stockholm, Sweden) (2022)
Our study showed no difference in total societal costs between the comprehensive exercise intervention and UC or between the exercise intensities. This suggests that exercise, with its well-documented health benefits during oncological treatment, produces neither additional costs nor savings.